| Dr Herbert B Weingard, MD | |
|
13851 E 14th St, Suite 200, San Leandro, CA 94578-2631 | |
| (510) 351-2100 | |
| (510) 357-3389 |
| Full Name | Dr Herbert B Weingard |
|---|---|
| Gender | Male |
| Speciality | Family Medicine |
| Location | 13851 E 14th St, San Leandro, California |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1275646721 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | G24892 (California) | Primary |
| Entity Name | Dhhs Phs Naihs Shiprock Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1780639971 PECOS PAC ID: 0749193837 Enrollment ID: O20031105000809 |
News Archive
Today, the U.S. Food and Drug Administration approved the first generic of glucagon for injection USP, 1 mg/vial packaged in an emergency kit, for the treatment of severe hypoglycemia (very low blood sugar), which may occur in patients with diabetes mellitus.
Children of melanoma survivors were more likely to wear hats and re-apply sunscreen after receiving a multi-media informational program designed specifically for them. These new findings were included in research published in the journal of Cancer Epidemiology, Biomarkers and Prevention - a publication of the American Association for Cancer Research.
In one of the big NHS blunders, nearly 800,000 people who have pledged one or more of their organs for donation may have had their preferences of which organ/s recorded incorrectly for the past 10 years. There are nearly 17 million donors who consent to give all their organs. However some have preferences and withhold consent for some organs like eyes, skin or heart etc. Some had also expressed their wish that their body tissue should not be used in research after their death. This huge error came to public notice in 2009 when the NHS Blood and Transplant started sending out mails to potential donors to check their preferences. Many people wrote back that the information in the records were not right.
Roche announced today that the company has obtained a worldwide co-exclusive license for the biomarker PI3K (phosphoinositide 3-kinase) from QIAGEN to develop real-time and endpoint PCR diagnostic assays. Johns Hopkins University owns the patent for the PI3K biomarker and has previously granted an exclusive license to QIAGEN's wholly owned subsidiary DxS, now QIAGEN Manchester.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Herbert B Weingard, MD 13851 E 14th St, Suite 200, San Leandro, CA 94578-2631 Ph: (510) 351-2100 | Dr Herbert B Weingard, MD 13851 E 14th St, Suite 200, San Leandro, CA 94578-2631 Ph: (510) 351-2100 |
News Archive
Today, the U.S. Food and Drug Administration approved the first generic of glucagon for injection USP, 1 mg/vial packaged in an emergency kit, for the treatment of severe hypoglycemia (very low blood sugar), which may occur in patients with diabetes mellitus.
Children of melanoma survivors were more likely to wear hats and re-apply sunscreen after receiving a multi-media informational program designed specifically for them. These new findings were included in research published in the journal of Cancer Epidemiology, Biomarkers and Prevention - a publication of the American Association for Cancer Research.
In one of the big NHS blunders, nearly 800,000 people who have pledged one or more of their organs for donation may have had their preferences of which organ/s recorded incorrectly for the past 10 years. There are nearly 17 million donors who consent to give all their organs. However some have preferences and withhold consent for some organs like eyes, skin or heart etc. Some had also expressed their wish that their body tissue should not be used in research after their death. This huge error came to public notice in 2009 when the NHS Blood and Transplant started sending out mails to potential donors to check their preferences. Many people wrote back that the information in the records were not right.
Roche announced today that the company has obtained a worldwide co-exclusive license for the biomarker PI3K (phosphoinositide 3-kinase) from QIAGEN to develop real-time and endpoint PCR diagnostic assays. Johns Hopkins University owns the patent for the PI3K biomarker and has previously granted an exclusive license to QIAGEN's wholly owned subsidiary DxS, now QIAGEN Manchester.
› Verified 2 days ago
Bruce A Robertson, M.D Family Medicine Medicare: Medicare Enrolled Practice Location: 13851 E 14th St, Suite 102, San Leandro, CA 94578 Phone: 510-351-2100 Fax: 510-357-3389 | |
Dr. Douglas D Zhang, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 13851 E 14th St, San Leandro, CA 94578 Phone: 510-351-2100 Fax: 510-357-3389 | |
Miss Somia Mohanty, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 2500 Merced St, San Leandro, CA 94577 Phone: 510-362-6303 | |
Dr. Jane Helen Wardzinska, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 13847 E 14th St, Suite 110, San Leandro, CA 94578 Phone: 510-895-8700 Fax: 510-895-8725 | |
Willis L Gelston, M.D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 13851 E 14th St, Suite 102, San Leandro, CA 94578 Phone: 510-351-2100 Fax: 510-357-3389 | |
Anatoly Brodsky, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 2500 Merced St, Internal Medicine Department, San Leandro, CA 94577 Phone: 510-454-4010 |